PFE Pfizer Inc.
Healthcare$25.90-0.19%ClosedMarket Cap: $147.62B
As of 2026-05-25
Valuation
P/E (TTM)
19.91
PEG
—
P/B
1.64
P/S
2.33
EV/EBITDA
12.42
DCF Value
$38.72
FCF Yield
6.4%
Div Yield
6.6%
Margins & Returns
Gross Margin
69.3%
Operating Margin
23.4%
Net Margin
11.8%
ROE
8.4%
ROA
3.6%
ROIC
8.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $14.45B | 67.3% | $4.03B | $2.69B | $— | $0.43 |
| Q4 null | $17.56B | 70.0% | $3.69B | $-1.65B | $— | $0.43 |
| FY null | $62.58B | 70.3% | $15.44B | $7.77B | $— | $1.72 |
| Q3 null | $16.65B | 74.9% | $3.55B | $3.54B | $— | $0.43 |
| Q2 null | $14.65B | 64.3% | $3.58B | $2.91B | $— | $0.43 |
| Q1 null | $13.71B | 71.7% | $4.62B | $2.97B | $— | $0.43 |
| Q4 null | $17.76B | 73.0% | $5.72B | $403.0M | $— | $0.42 |
| FY null | $63.63B | 65.8% | $16.48B | $8.02B | $— | $1.68 |
| Q3 null | $17.70B | 60.8% | $4.97B | $4.47B | $— | $0.42 |
| Q2 null | $13.28B | 62.1% | $1.88B | $24.0M | $— | $0.42 |
| Q1 null | $14.88B | 70.6% | $4.56B | $3.12B | $— | $0.42 |
| Q4 2023 | $14.57B | 41.0% | $-1.26B | $-3.34B | $-0.60 | $0.41 |